Today, the U.S. Food and Drug Administration announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the matter of additional doses of COVID-19 vaccines and specifically to discuss the Pfizer-BioNTech supplemental Biologics License Application for administration of a “booster” dose of Comirnaty (COVID-19 Vaccine, mRNA) in individuals 16 years of age and older.

The meeting will be held on Sept. 17, 2021, from 8:30 a.m. to 3:45 p.m. EST. The FDA intends to livestream the VRBPAC meeting on the agency’s YouTube channel; the meeting will also be webcast from the FDA website.

The FDA intends to make background material available to the public, including the meeting agenda and committee roster, no later than two business days before the meeting.

Read the full news release in English.